Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers M > Headlines for Martek Biosciences Corp. > News item |
Martek initiated by Merrill Lynch at sell
Martek Biosciences Corp. coverage was initiated by Merrill Lynch analyst David Munno at a sell rating. Martek shares Friday were down $0.45, or 1.24%, at $35.92 on volume of 1,114,189 shares versus the three-month running average of 742,225 shares.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.